3rd Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$405,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Monitor legislation pertainin to medicare, including Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629).

Foreign entity interest: Eisai Co. Ltd., Based in Tokyo Japan and as identiified in our lobbying registration has an interest as a pharmaceutical company and all of the issues with respect to which Eisai Inc. has lobbyed and listed above.

LobbyistCovered position, as disclosed
ROBERT FEENEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5629 (110th), H.R. 1908 (110th)

Defense DEF

Monitor legislation pertainin to medicare, including Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Physician Payment Sunshine Act of 2007 (S2029), Medicare Improvements for Patients and Providers Act of 2008 (S3101), Medicare Improvements for Patients and Providers Act of 2008 (HR6331), Budget resolution FY2009 (H.Com.Res.312), FY09 Department of Defense Authorization.

Foreign entity interest: Eisai Co. Ltd., Based in Tokyo Japan and as identiified in our lobbying registration has an interest as a pharmaceutical company and all of the issues with respect to which Eisai Inc. has lobbyed and listed above.

LobbyistCovered position, as disclosed
ROBERT FEENEY —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6331 (110th), H.R. 1908 (110th), H.R. 5629 (110th)

Copyright/Patent/Trademark CPT

Monitor legislation pertainin to medicare, including Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Physician Payment Sunshine Act of 2007 (S2029), Medicare Improvements for Patients and Providers Act of 2008 (S3101), Medicare Improvements for Patients and Providers Act of 2008 (HR6331), Budget resolution FY2009 (H.Com.Res.312), FY09 Department of Defense Authorization.

Foreign entity interest: Eisai Co. Ltd., Based in Tokyo Japan and as identiified in our lobbying registration has an interest as a pharmaceutical company and all of the issues with respect to which Eisai Inc. has lobbyed and listed above.

LobbyistCovered position, as disclosed
ROBERT FEENEY —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 5629 (110th), H.R. 1908 (110th), H.R. 6331 (110th)

Health Issues HCR

Monitor legislation pertainin to medicare, including Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Physician Payment Sunshine Act of 2007 (S2029), Medicare Improvements for Patients and Providers Act of 2008 (S3101), Medicare Improvements for Patients and Providers Act of 2008 (HR6331), Budget resolution FY2009 (H.Com.Res.312), FY09 Department of Defense Authorization.

Foreign entity interest: Eisai Co. Ltd., Based in Tokyo Japan and as identiified in our lobbying registration has an interest as a pharmaceutical company and all of the issues with respect to which Eisai Inc. has lobbyed and listed above.

LobbyistCovered position, as disclosed
ROBERT FEENEY —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 5629 (110th), H.R. 6331 (110th), H.R. 1908 (110th)

Medicare/Medicaid MMM

Monitor legislation pertainin to medicare, including Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Physician Payment Sunshine Act of 2007 (S2029), Medicare Improvements for Patients and Providers Act of 2008 (S3101), Medicare Improvements for Patients and Providers Act of 2008 (HR6331), Budget resolution FY2009 (H.Com.Res.312), FY09 Department of Defense Authorization.

Foreign entity interest: Eisai Co. Ltd., Based in Tokyo Japan and as identiified in our lobbying registration has an interest as a pharmaceutical company and all of the issues with respect to which Eisai Inc. has lobbyed and listed above.

LobbyistCovered position, as disclosed
ROBERT FEENEY —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5629 (110th), H.R. 1908 (110th), H.R. 6331 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.